Cutting back on all the device samples, looking hard at injectable business ,looks like preparing p&l for a sell.....
anonymous
Guest
anonymous
Guest
Nobody will buy this crappy product lineup.Cutting back on all the device samples, looking hard at injectable business ,looks like preparing p&l for a sell.....
Joke of the industry.
anonymous
Guest
anonymous
Guest
Should have sold the business in 2015. It’s been downhill ever since the acquisition of Ulthera.
Not sure which company would want to buy Merz. It’s a 3rd league player with amateur leadership.
Not sure which company would want to buy Merz. It’s a 3rd league player with amateur leadership.
anonymous
Guest
anonymous
Guest
Products are crap.
Sales reps only chance at getting orders are with BOGO deals to offices. Used car sales approach to injectable business. Joke of the industry.
Sales reps only chance at getting orders are with BOGO deals to offices. Used car sales approach to injectable business. Joke of the industry.
anonymous
Guest
anonymous
Guest
Truthful statements on this thread.
Good intentions wrong leaders. Too late now.
Not sure how this company still exists with no decent sales or profit.
Good intentions wrong leaders. Too late now.
Not sure how this company still exists with no decent sales or profit.
anonymous
Guest
anonymous
Guest
Products are crap.
Sales reps only chance at getting orders are with BOGO deals to offices. Used car sales approach to injectable business. Joke of the industry.
Cement produces a better aesthetic result than Radiesse.
anonymous
Guest
anonymous
Guest
Radiesse & Ulthera are dangerousCement produces a better aesthetic result than Radiesse.
Xeomin does not last
Neocutis is dead
..... what does this company have to sell????
anonymous
Guest
anonymous
Guest
Products are dogs.
Any account in my territory that uses Radiesse gets at least 5 free for every 10 purchased.
Xeomin is always buy one get one.
Any account in my territory that uses Radiesse gets at least 5 free for every 10 purchased.
Xeomin is always buy one get one.
anonymous
Guest
anonymous
Guest
It’s a race to the bottom!Products are dogs.
Any account in my territory that uses Radiesse gets at least 5 free for every 10 purchased.
Xeomin is always buy one get one.
anonymous
Guest
anonymous
Guest
Word on the street from Private Equity firms is that Merz could finally be up for sale in 2022.
anonymous
Guest
anonymous
Guest
Merz’s portfolio is quite good. Product perception less so. Commercial execution in US, EMEA, APAC & LATAM is a disaster. Leadership is asleep at the wheel. The business needs a shake-up!
anonymous
Guest
anonymous
Guest
Why does Merz still not turn out any decent profit? Mediocrity seems to be tolerated by the owners.
anonymous
Guest
anonymous
Guest
Agreed but difficult to get good talent to come here.Merz’s portfolio is quite good. Product perception less so. Commercial execution in US, EMEA, APAC & LATAM is a disaster. Leadership is asleep at the wheel. The business needs a shake-up!
anonymous
Guest
anonymous
Guest
No one wants to work for a 3rd league company without any ambition, energy and drive.Agreed but difficult to get good talent to come here.
anonymous
Guest
anonymous
Guest
Do you get any equity when you come on board?
anonymous
Guest
anonymous
Guest
No. Far too conservative company. Pays well but no incentive to outperform the market.Do you get any equity when you come on board?